Ratings by TD Cowen (Yaron Werber)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/26/2024 | Stoke Therapeutics | STOK | Upgrade | Buy (Hold) |
6.50 (13.50) |
107.69% | Details | |
3/21/2024 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
3/18/2024 | Jasper Therapeutics | JSPR | New Coverage | Buy (N/A) |
25.08 (29.36) |
17.07% | Details | |
3/15/2024 | Immuneering Corporation | IMRX | Downgrade | Hold (Buy) |
5.88 (2.89) |
-50.85% | Details | |
1/31/2024 | 2Seventy Bio Inc. | TSVT | Downgrade | Hold (Buy) |
3.49 (5.35) |
53.3% | Details | |
1/25/2024 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
1/10/2024 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
12/21/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
12/20/2023 | Celldex Therapeutics | CLDX | New Coverage | Buy (N/A) |
37.92 (41.97) |
10.68% | Details | |
12/19/2023 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
12/12/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
11/7/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
10/19/2023 | Generation Bio | GBIO | Downgrade | Hold (Buy) |
3.11 (4.07) |
30.87% | Details | |
8/8/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
7/28/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
7/25/2023 | Stoke Therapeutics | STOK | Downgrade | Hold (Buy) |
9.53 (13.50) |
41.66% | Details | |
7/17/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
6/26/2023 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
5/8/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
3/28/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
2/28/2023 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
2/27/2023 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
1/25/2023 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
1/25/2023 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
1/25/2023 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
11/3/2022 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
11/3/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
11/2/2022 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
11/1/2022 | Legend Biotech Corp. | LEGN | New Coverage | Buy (N/A) |
49.82 (56.09) |
12.59% | Details | |
11/1/2022 | Instil Bio Inc | TIL | Downgrade | Hold (Buy) |
5.25 (10.80) |
105.71% | Details | |
8/17/2022 | BioNTech | BNTX | Maintain | Hold (N/A) |
|
Details | ||
8/9/2022 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
5/12/2022 | Ascendis Pharma | ASND | Maintain | Hold (N/A) |
|
Details | ||
5/10/2022 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
5/2/2022 | Genmab A/S | GMAB | New Coverage | Hold (N/A) |
35.07 (29.91) |
-14.71% | Details | |
4/6/2022 | bluebird bio | BLUE | Downgrade | Hold (Buy) |
5.23 (1.28) |
-75.53% | Details | |
3/31/2022 | Orchard Therapeutics | ORTX | Downgrade | Hold (Buy) |
0.78 (16.70) |
2041.03% | Details | |
1/27/2022 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
1/27/2022 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
1/10/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
1/6/2022 | 2Seventy Bio Inc. | TSVT | New Coverage | Buy (N/A) |
22.89 (5.35) |
-76.63% | Details | |
1/6/2022 | Ascendis Pharma | ASND | New Coverage | Hold (N/A) |
123.37 (151.17) |
22.53% | Details | |
1/6/2022 | 2Seventy Bio | TSTV | New Coverage | Buy (N/A) |
0.00 () |
0% | Details | |
11/30/2021 | IO Biotech | IOBT | New Coverage | Buy (N/A) |
8.74 (1.73) |
-80.21% | Details | |
11/5/2021 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
10/26/2021 | Roivant Sciences | ROIV | New Coverage | Buy (N/A) |
7.04 (10.54) |
49.72% | Details | |
10/1/2021 | Acceleron Pharma | XLRN | Downgrade | Hold (Buy) |
175.36 (178.75) |
1.93% | Details | |
9/27/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
8/24/2021 | Immuneering Corporation | IMRX | New Coverage | Buy (N/A) |
29.43 (5.88) |
-80.02% | Details | |
8/6/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Hold (Buy) |
37.92 (38.22) |
0.79% | Details | |
7/16/2021 | FibroGen | FGEN | Maintain | Hold (N/A) |
|
Details | ||
6/28/2021 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
6/23/2021 | PMV Pharmaceuticals Inc. | PMVP | New Coverage | Buy (N/A) |
31.03 (1.70) |
-94.52% | Details | |
4/13/2021 | Instil Bio Inc | TIL | New Coverage | Buy (N/A) |
21.94 (10.80) |
-50.77% | Details | |
3/8/2021 | Nuvation Bio Inc | NUVB | New Coverage | Buy (N/A) |
10.86 (3.64) |
-66.48% | Details | |
2/18/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
2/18/2021 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
2/18/2021 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
2/3/2021 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
12/16/2020 | Prevail Therapeutics | PRVL | Downgrade | Hold (Buy) |
12.50 (23.00) |
84% | Details | |
12/15/2020 | Ionis Pharmaceuticals | IONS | Upgrade | Buy (Hold) |
47.83 (43.35) |
-9.37% | Details | |
12/14/2020 | Olema Pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
43.28 (10.47) |
-75.81% | Details | |
11/17/2020 | Foghorn Therapeutics | FHTX | New Coverage | Buy (N/A) |
16.05 (6.71) |
-58.19% | Details | |
11/6/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
10/29/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
10/28/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
10/22/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
8/10/2020 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
40.69 (8.30) |
-79.6% | Details | |
8/7/2020 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
8/6/2020 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
7/30/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
7/29/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
7/16/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
7/7/2020 | Generation Bio | GBIO | New Coverage | Buy (N/A) |
19.64 (4.07) |
-79.28% | Details | |
6/25/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
6/2/2020 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
5/26/2020 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
5/6/2020 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
5/1/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
5/1/2020 | FibroGen | FGEN | New Coverage | Hold (N/A) |
36.89 (2.35) |
-93.63% | Details | |
2/24/2020 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
1/31/2020 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
1/28/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
1/24/2020 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
12/20/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
12/19/2019 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
12/16/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
12/16/2019 | argenx SE | ARGX | Maintain | Buy (N/A) |
|
Details | ||
11/13/2019 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
11/5/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
10/31/2019 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
10/30/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
10/29/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
10/8/2019 | Spring Works Therapeutics | SWTX | New Coverage | Buy (N/A) |
18.67 (49.22) |
163.63% | Details | |
9/16/2019 | argenx SE | ARGX | New Coverage | Buy (N/A) |
124.89 (393.72) |
215.25% | Details | |
9/16/2019 | Orchard Therapeutics | ORTX | New Coverage | Buy (N/A) |
15.03 (16.70) |
11.11% | Details | |
8/26/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
8/26/2019 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
7/15/2019 | Stoke Therapeutics | STOK | New Coverage | Buy (N/A) |
27.85 (13.50) |
-51.53% | Details | |
7/15/2019 | Prevail Therapeutics | PRVL | New Coverage | Buy (N/A) |
12.13 (23.00) |
89.61% | Details | |
6/14/2019 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
5/7/2019 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
5/2/2019 | Exelixis | EXEL | Maintain | Buy (N/A) |
|
Details | ||
3/4/2019 | Alector Inc. | ALEC | New Coverage | Buy (N/A) |
19.59 (6.02) |
-69.27% | Details | |
2/26/2019 | Zafgen | ZFGN | New Coverage | Hold (N/A) |
4.84 (0.99) |
-79.55% | Details | |
2/26/2019 | Rocket Pharmaceuticals | RCKT | New Coverage | Buy (N/A) |
14.88 (26.94) |
81.05% | Details | |
2/26/2019 | Unum Therapeutics | UMRX | New Coverage | Hold (N/A) |
4.24 (2.35) |
-44.58% | Details | |
2/26/2019 | Dicerna Pharmaceuticals | DRNA | New Coverage | Buy (N/A) |
10.51 (38.22) |
263.65% | Details | |
2/26/2019 | Exelixis | EXEL | New Coverage | Buy (N/A) |
21.52 (23.73) |
10.27% | Details | |
2/26/2019 | Amgen | AMGN | New Coverage | Buy (N/A) |
187.50 (284.32) |
51.64% | Details | |
2/26/2019 | BeiGene, Ltd. | BGNE | New Coverage | Buy (N/A) |
137.78 (156.39) |
13.51% | Details | |
2/26/2019 | Celgene | CELG | New Coverage | Hold (N/A) |
89.14 (108.24) |
21.43% | Details | |
2/26/2019 | bluebird bio | BLUE | New Coverage | Buy (N/A) |
131.32 (1.28) |
-99.03% | Details | |
2/26/2019 | Ultragenyx Pharma | RARE | New Coverage | Buy (N/A) |
59.82 (46.69) |
-21.95% | Details | |
2/26/2019 | Epizyme | EPZM | New Coverage | Buy (N/A) |
11.85 (1.47) |
-87.59% | Details | |
2/26/2019 | Acceleron Pharma | XLRN | New Coverage | Buy (N/A) |
42.74 (178.75) |
318.23% | Details |